We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+486.29%
AUM
$415B
AUM Growth
+$20.2B
Cap. Flow
-$5.07B
Cap. Flow %
-1.22%
Top 10 Hldgs %
11.8%
Holding
4,196
New
190
Increased
1,645
Reduced
2,044
Closed
170

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$913M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$818M
3
MSFT icon
Microsoft
MSFT
+$369M
4
MDB icon
MongoDB
MDB
+$345M
5
GRAB icon
Grab
GRAB
+$339M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$867M
2
PYPL icon
PayPal
PYPL
+$519M
3
BABA icon
Alibaba
BABA
+$393M
4
CRWD icon
CrowdStrike
CRWD
+$360M
5
DOCU
DocuSign
DOCU
+$335M

Sector Composition

Rank Sector Weight
1 Technology 21.56%
2 Healthcare 12.66%
3 Financials 12.55%
4 Consumer Discretionary 11.59%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNXP icon
3901
Tonix Pharmaceuticals
TNXP
$201M
– –
0
– –
VIRX
3902
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$41K ﹤0.01%
11,335
-400
-3% -$2.13K
AGMH icon
3903
AGM Group Holdings
AGMH
$2.41M
$40K ﹤0.01%
329
+30
+10% +$13.3K
ATNX
3904
DELISTED
Athenex, Inc. Common Stock
ATNX
$40K ﹤0.01%
1,470
-452
-24% -$19.1K
AMPE
3905
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$38K ﹤0.01%
224
-150
-40% -$55.9K
MBIO icon
3906
Mustang Bio
MBIO
$4.47M
$36K ﹤0.01%
29
– –
PBYI icon
3907
Puma Biotechnology
PBYI
$442M
$36K ﹤0.01%
11,820
-3,550
-23% -$15.4K
AMRN
3908
Amarin Corp
AMRN
$298M
$35K ﹤0.01%
511
-485
-49% -$40.2K
UAVS icon
3909
AgEagle Aerial Systems
UAVS
$59.2M
$34K ﹤0.01%
22
-21
-49% -$50.9K
AQB icon
3910
AquaBounty Technologies
AQB
$7.05M
$33K ﹤0.01%
795
-68
-8% -$4.38K
ARDX icon
3911
Ardelyx
ARDX
$997M
$33K ﹤0.01%
30,189
-8,596
-22% -$10.2K
AVTX icon
3912
Avalo Therapeutics
AVTX
$1.06B
$33K ﹤0.01%
7
– –
IBIO icon
3913
iBio
IBIO
$69.5M
$33K ﹤0.01%
122
-14
-10% -$5.34K
SLDB icon
3914
Solid Biosciences
SLDB
$918M
$32K ﹤0.01%
1,242
-307
-20% -$9.38K
QTT
3915
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$32K ﹤0.01%
11,381
+1,324
+13% +$9.88K
OGI
3916
Organigram Holdings
OGI
$148M
$31K ﹤0.01%
4,480
– –
SVRN
3917
OceanPal Inc
SVRN
$11.8M
– –
0
– –
TRVN
3918
DELISTED
Trevena, Inc.
TRVN
$29K ﹤0.01%
79
-7
-8% -$3.88K
SMMT icon
3919
Summit Therapeutics
SMMT
$11.9B
$28K ﹤0.01%
10,689
-8,478
-44% -$40.8K
ONCT
3920
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$28K ﹤0.01%
623
-72
-10% -$4.84K
LVO icon
3921
LiveOne
LVO
$60.4M
$26K ﹤0.01%
2,017
+97
+5% +$2.13K
WPRT
3922
Westport Fuel Systems
WPRT
$35.7M
$25K ﹤0.01%
1,043
– –
MBII
3923
DELISTED
Marrone Bio Innovations, Inc.
MBII
$25K ﹤0.01%
34,740
-1,066
-3% -$862
ZOM
3924
DELISTED
Zomedica Corp.
ZOM
$25K ﹤0.01%
81,457
-667
-0.8% -$300
HOFV
3925
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$24K ﹤0.01%
707
-78
-10% -$3.69K
155 156
157
158 159

Similar funds

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco's Q4 2021 Portfolio in Review

As of Q4 2021, Invesco held 4,196 positions worth $415B, up 5.1% from $395B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Invesco's Q4 2021 filing shows 190 new, 1,645 increased, 2,044 reduced and 170 closed positions. Its largest new stake was Grab: 44,484,753 shares worth $317M. The largest sale was Meta Platforms (Facebook), an estimated $867M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Invesco's largest Q4 2021 buy was Grab: 44,484,753 shares worth $317M.
  • Invesco added most to Apple in Q4 2021, an estimated $913M increase.
  • Invesco's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $867M.
  • Invesco fully exited Kansas City Southern in Q4 2021, selling an estimated $110M.
  • Invesco's ten largest holdings make up 12% of its $415B portfolio in Q4 2021.
  • Invesco opened 190 new positions and closed 170 in Q4 2021.
  • Invesco's portfolio value rose 5.1% quarter-over-quarter to $415B.

Based on Invesco's 13F filing for Q4 2021, filed 14 Feb 2022.